BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6111983)

  • 1. Antinoradrenergic activity of thymoxamine and its metabolites in rats.
    Roquebert J; Demichel P; Malek A
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):12-25. PubMed ID: 6111983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo alpha-blocking activity of thymoxamine and its two metabolites.
    Creuzet MH; Prat G; Malek A; Fauran F; Roquebert J
    J Pharm Pharmacol; 1980 Mar; 32(3):209-13. PubMed ID: 6103939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of the pre and post-synaptic alpha blocking activity of thymoxamine and its metabolites in the rat vas deferens (author's transl)].
    Roquebert J; Demichel P; Malek A; Canellas J
    J Pharmacol; 1981; 12(1):15-25. PubMed ID: 6111626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antinoradrenergic activity of raubasine on isolated thoracic aorta and vas deferens of rat (author's transl)].
    Roquebert J; Gomond P; Demichel P
    J Pharmacol; 1981; 12(4):393-403. PubMed ID: 6119400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thymoxamine and its metabolites on clonidine-induced hypotension and bradycardia in rats.
    Roquebert J; Demichel P; Malek A
    Arch Int Pharmacodyn Ther; 1982 Jul; 258(1):116-27. PubMed ID: 6215903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nipradilol (K-351) on alpha-adrenoceptor mediated responses in various isolated tissues.
    Ohira A; Wada Y; Fujii M; Nakamura M; Kasuya Y; Hamada Y; Shigenobu K
    Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):61-71. PubMed ID: 2869737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Action of dihydroergocristine at pre- and postsynaptic alpha-adrenoceptors in the rat isolated vas deferens].
    Roquebert J; Demichel P; Gomond P; Malek A
    J Pharmacol; 1983; 14(2):151-9. PubMed ID: 6134866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation of urapidil: metabolites in serum and urine and their biological activity in vitro and in vivo.
    Zech K; Eltze M; Kilian U; Sanders KH; Kolassa N
    Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):180-96. PubMed ID: 6098228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-specific, time-dependent desensitization of the vas deferens and anococcygeus preparations of the rat to alpha 1-adrenoceptor antagonists and atropine.
    Onnen I
    Br J Pharmacol; 1984 Sep; 83(1):7-14. PubMed ID: 6148980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nomifensine on the isolated vas deferens of the rat.
    Tayo FM
    Arch Int Pharmacodyn Ther; 1979 Jul; 240(1):94-102. PubMed ID: 508001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of indoramin in rat vas deferens and aorta: concomitant alpha1-adrenoceptor and neuronal uptake blockade.
    Pupo AS; Cavenaghi DL; Campos M; Lucena Morais P; Jurkiewicz NH; Jurkiewicz A
    Br J Pharmacol; 1999 Aug; 127(8):1832-6. PubMed ID: 10482913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: Is thymoxamine a specific alpha-adrenoceptor blocking agent?
    Fawke L
    Br J Pharmacol; 1972 Feb; 44(2):362P-362P. PubMed ID: 4148921
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha1A-adrenoceptor mediated contraction of rat prostatic vas deferens and the involvement of ryanodine stores and Ca2+ influx stimulated by diacylglycerol and PKC.
    Burt RP; Chapple CR; Marshall I
    Br J Pharmacol; 1998 Jan; 123(2):317-25. PubMed ID: 9489621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha-adrenoceptor blocking properties of cryptolepine on the rat isolated vas deferens. Studies on cryptolepine.
    Noamesi BK; Bamgbose SO
    Planta Med; 1980 May; 39(1):51-6. PubMed ID: 6105685
    [No Abstract]   [Full Text] [Related]  

  • 15. The evaluation of the alpha-adrenoceptor blocking action of indoramin, phentolamine and thymoxamine on the rat and guinea-pig isolated mesenteric vasculature and aortic spiral preparations.
    Collis MG; Alps BJ
    J Pharm Pharmacol; 1973 Aug; 25(8):621-8. PubMed ID: 4148430
    [No Abstract]   [Full Text] [Related]  

  • 16. Design and evaluation of nitrosylated alpha-adrenergic receptor antagonists as potential agents for the treatment of impotence.
    de Tejada IS; Garvey DS; Schroeder JD; Shelekhin T; Letts LG; Fernández A; Cuevas B; Gabancho S; Martínez V; Angulo J; Trocha M; Marek P; Cuevas P; Tam SW
    J Pharmacol Exp Ther; 1999 Jul; 290(1):121-8. PubMed ID: 10381767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 1- and alpha 2-adrenoceptor selectivity of moxisylyte (thymoxamine) and its metabolites in the pithed rat.
    Roquebert J; Malek A; Creuzet MH; Cognie F; Pontagnier H
    Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):282-93. PubMed ID: 6320755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymoxamine on the guinea-pig vas deferens: an effect unrelated to alpha-receptor blockade.
    Fawke L
    Arch Int Pharmacodyn Ther; 1973 Aug; 204(2):316-25. PubMed ID: 4147880
    [No Abstract]   [Full Text] [Related]  

  • 19. [The blocking and partial agonistic actions of jatrorrhizine on alpha-adrenoceptors].
    Han H; Fang DC
    Zhongguo Yao Li Xue Bao; 1989 Sep; 10(5):385-9. PubMed ID: 2575836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-adrenoceptor-blocking properties of some trypanocidal diamidines.
    Steinmann U; Estler CJ; Dann O
    Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):207-14. PubMed ID: 2895613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.